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Key points
 Sustained hypoxic exposure increases ventilatory sensitivity to hypoxia as part of physiological
acclimatisation.
 Oxygen-sensitive signals are transduced in animal cells by post-translational hydroxylation of
transcription factors termed hypoxia-inducible factors (HIFs).
 Mice heterozygous for the principal ‘oxygen-sensing’ HIF hydroxylase PHD2 (prolyl hydro-
xylase domain 2) show enhanced ventilatory sensitivity to hypoxia.
 To analyse the underlying mechanisms, functional (hypoxic ventilatory responses, HVRs) and
anatomical (cellular proliferation within carotid bodies) responses were studied in genetic
models of inducible and constitutive inactivation of PHD2 and its principal hydroxylation
substrates, HIF-1α and HIF-2α.
 Inducible PHD2 inactivation enhanced HVR, similar to constitutive inactivation; both
responses were almost entirely compensated for by specific inactivation of HIF-2α.
 Inducible inactivation of HIF-2α, but not HIF-1α, strikingly reduced ventilatory
acclimatisation to hypoxia and associated carotid body cell proliferation.
 These findings demonstrate a key role for PHD2 andHIF-2α in ventilatory control and carotid
body biology.
Abstract Ventilatory sensitivity to hypoxia increases in response to continued hypoxic exposure
as part of acute acclimatisation. Although this process is incompletely understood, insights have
been gained through studies of the hypoxia-inducible factor (HIF) hydroxylase system. Genetic
studies implicate these pathways widely in the integrated physiology of hypoxia, through effects
on developmental or adaptive processes. In keeping with this, mice that are heterozygous for
the principal HIF prolyl hydroxylase, PHD2, show enhanced ventilatory sensitivity to hypoxia
and carotid body hyperplasia. Here we have sought to understand this process better through
comparative analysis of inducible and constitutive inactivation of PHD2 and its principal
targets HIF-1α and HIF-2α. We demonstrate that general inducible inactivation of PHD2 in
tamoxifen-treated Phd2f/f;Rosa26+/CreERT2 mice, like constitutive, heterozygous PHD2 deficiency,
enhances hypoxic ventilatory responses (HVRs: 7.2 ± 0.6 vs. 4.4 ± 0.4 ml min−1 g−1 in controls,
P< 0.01). The ventilatory phenotypes associatedwith both inducible and constitutive inactivation
of PHD2 were strongly compensated for by concomitant inactivation of HIF-2α, but not HIF-1α.
Furthermore, inducible inactivation of HIF-2α strikingly impaired ventilatory acclimatisation to
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chronic hypoxia (HVRs: 4.1 ± 0.5 vs. 8.6 ± 0.5 ml min−1 g−1 in controls, P < 0.0001), as well as
carotid body cell proliferation (400± 81 vs. 2630± 390 bromodeoxyuridine-positive cells mm−2
in controls, P < 0.0001). The findings demonstrate the importance of the PHD2/HIF-2α
enzyme–substrate couple in modulating ventilatory sensitivity to hypoxia.
(Received 15 June 2015; accepted after revision 26 August 2015; first published online 4 September 2015)
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Introduction
The control of breathing is a fundamental component
of oxygen homeostasis, and ventilation increases within
seconds in response to hypoxaemia. This acute hypo-
xic ventilatory response (HVR) defends against hypo-
xia, but is limited by hyperventilation-induced hypo-
capnia. With exposure to more prolonged hypoxia, a
further progressive increase in ventilation and arterial
oxygenation develops over a period of hours to days in
spite of the hypocapnia. This secondary response, often
referred to as ventilatory acclimatisation to hypoxia (VAH;
reviewed by Robbins, 2007), is associated with an increase
in chemoreceptor sensitivity and, whilst usually associated
with adaptation to altitude, is also important in diseases
associatedwith chronic hypoxaemia.Despite intense study
in many species, the mechanisms underlying chemo-
receptor acclimatisation remain largely unknown. An
understanding of this process could, however, represent an
important target for therapeutic control of chemoreceptor
activity.
Molecular insights into the regulation of gene
expression by the hypoxia-inducible factor (HIF) system
have generated new opportunities for the understanding
of such physiological responses to hypoxia (reviewed
by Kaelin & Ratcliffe, 2008; Prabhakar & Semenza,
2012; Ratcliffe, 2013). HIF is an α/β heterodimeric
transcription factor whose α subunits are regulated by
oxygen levels through post-translational hydroxylation
of specific amino acid residues. The most important of
these is the prolyl hydroxylation of residues that promote
association of HIF-α proteins with von Hippel–Lindau
protein (pVHL) ubiquitin ligase and their subsequent
proteasomal degradation. HIF prolyl hydroxylation is
catalysed by the prolyl hydroxylase domain (PHD)
enzymes, a series of closely related enzymes belonging to
the 2-oxoglutarate-dependent dioxygenase family. A fall in
oxygen availability impairs prolyl hydroxylation allowing
HIF-α proteins to escape destruction and form the trans-
criptional complex.
The HIF hydroxylase system is conserved throughout
the animal kingdom, consisting of a single PHD and
HIF-α in the simplest animal Trichloplax, but under-
going whole genome duplications and deletions during
vertebrate evolution, resulting in multiple copies of both
HIF-α (of which 1 and 2 are the best characterised)
and PHD (1, 2 and 3) in mammals (Loenarz et al.
2010). Although PHD2 is the most abundant enzyme
and the main regulator of HIF-1α (Berra et al. 2003;
Appelhoff et al.2004), all PHDenzymes are able to regulate
both HIF-1α and HIF-2α, with PHD1 and 3 having
relatively greater action on HIF-2α in some cell lines.
Transcriptional profiling of HIF-1α and HIF-2α at the
cellular level indicates that they activate distinct, although
partially overlapping, sets of target genes (Mole et al. 2009;
Scho¨del et al. 2012), generating interest in understanding
the existence and nature of their differentiated physio-
logical functions (Keith et al. 2012; Prabhakar & Semenza,
2012). Interestingly, despite HIF-1α being the principal
target of PHD2 in cell lines, studies in intact animals have
identified a specific role for the PHD2/HIF-2α couple in
the regulation of erythropoiesis (Arsenault et al. 2013;
Franke et al. 2013), a major component of acclimatisation
to altitude.
The PHD/HIF system has also been shown to play an
important part in ventilatory acclimatisation (Kline et al.
2002; Peng et al. 2006, 2011; Bishop et al. 2013; Yuan
et al. 2013). Studies to date have investigated ventilatory
control inmicewith heterozygous loss ofPhd2,Hif-1α and
Hif-2α, which are viable and have no major phenotype
in normoxia (Yu et al. 1999; Brusselmans et al. 2003;
Aragones et al. 2008; Mazzone et al. 2009) – unlike their
homozygous counterparts which are embryonic lethal
(Carmeliet et al. 1998; Iyer et al. 1998; Kotch et al. 1999;
Peng et al. 2000; Compernolle et al. 2002, 2003; Takeda
et al. 2006) or, in the case ofHif-2α−/− mice, develop gross
abnormalities even if they survive embryonic development
(Compernolle et al. 2002; Scortegagna et al. 2003). For
instance, Phd2+/– mice show enhanced HVR similar to
that observed after chronic exposure to hypoxia and over-
growth of the carotid body (CB) (Bishop et al. 2013).
However, the PHD/HIF system also has profound effects
on development, including that of sympathoadrenal and
neuroendocrine systems that are relevant to ventilatory
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control (Tian et al. 1998; Compernolle et al. 2003; Bishop
et al. 2008; Pan et al. 2012; Kenchegowda et al. 2014).
The findings in constitutively heterozygous Phd2+/− mice
therefore raise important questions as to the extent to
which these effects are developmental as opposed to a
reflection of adaptive effects of hypoxia on the activity
of PHD2, and which targets (HIF-α proteins or other
proposed PHD2 substrates, e.g. Takahashi et al. 2011)
mediate the observed effects.
To address these questions we have performed
comparative studies of multiple genetic models that
reflect both inducible (acute) inactivation of PHD2 and
its principal HIF-α targets: HIF-1α and HIF-2α, and
constitutive (chronic) heterozygous inactivation of PHD2
and HIF-1/2α. Our findings reveal that acute inducible
inactivation of PHD2 increases ventilatory sensitivity to
hypoxia and that these effects are strongly dependent
on the integrity of HIF-2α. HIF-2α was also critical for
both the enhanced HVR, and the cellular proliferation
within the CB, which were observed in response to a
7-day exposure to chronic hypoxia. These effects were
reflected in the association of HIF-2α heterozygosity with
reduced ventilatory sensitivity, both in the context of
PHD2 heterozygosity and after chronic hypoxia. Together
our findings implicate the PHD2/HIF-2 couple as the
dominant mediator of enhanced HVR during ventilatory
acclimatisation to hypoxia, at least under the conditions
of our experiments.
Methods
Animals
All animal procedures were compliant with the UKHome
Office Animals (Scientific Procedures) Act 1986 and
Local Ethical Review Procedures (University of Oxford
Medical Sciences Division Ethical Review Committee).
The authors understand the ethical principles of The
Journal of Physiology and all work was conducted in
compliance with stated standards (Grundy, 2015). Male
mice, approximately 3monthsold and fromthe same litter,
were used for all comparisons, unless stated otherwise.
Phd2f/f, Hif-1αf/f and Hif-2αf/f (where f denotes the floxed
allele) conditional knockout and Rosa26CreERT2 mice have
all beendescribedpreviously andwereobtained fromthese
sources (Vooijs et al. 2001; Cramer et al. 2003; Higgins
et al. 2004; Gruber et al. 2007; Mazzone et al. 2009). Each
line had been backcrossed with C57BL/6 for at least five
generations (Adam et al. 2011) and was intercrossed to
generate littermates of appropriate genotypes. Phd2+/−,
Hif-1α+/− andHif-2α+/– mice are as described previously
(Carmeliet et al. 1998; Brusselmans et al. 2003; Mazzone
et al. 2009); these lines were intercrossed to generate mice
thatweremaintained on amixed Swiss/129/SvEv/C57BL/6
genetic background. Genotype was determined by PCR
(details on request). Mice were housed in individually
ventilated cages with free access to food and water.
Tamoxifen administration
Tamoxifen (prepared to 20 mg ml−1 in corn oil; Sigma,
St Louis, MO, USA) was administered by oral gavage
to 6-week-old mice at a dose of 2 mg day–1 for five
consecutive days as described by Arsenault et al. (2013).
Recombination was assessed using DNA isolated from ear
biopsies obtained 10 days after the first dose of tamoxifen
(PCR primers used to test for recombination are as
described by Adam et al. 2011). Ventilationmeasurements
were also taken (and chronic hypoxia treatment started) at
this timepoint, i.e. 10 days after the first tamoxifen dose, to
allow for assessment of ventilatory responses prior to the
onset of other steady-state, long-termeffects of PHD2/HIF
inactivation such as polycythaemia.
Plethysmography
Tidal volume and respiratory rate were measured in
awake, unrestrained mice using individual whole body
plethysmographs (600 ml volume; Model PLY4211,
Buxco, DSI, St. Paul, MI, USA). Minute ventilation
was calculated from tidal volume and respiratory rate.
Ventilatory parameters were derived using FinePointe
software (Buxco) and adjusted to bodyweight asmeasured
immediately prior to plethysmography. Premixed gas was
delivered to each chamber as described previously (Bishop
et al. 2013). The acute hypoxic stimuli consisted of 10%
oxygen, balance nitrogen or 10% oxygen, 3% carbon
dioxide, balance nitrogen. The HVR to each stimulus was
defined as the difference between minute ventilation (or
tidal volume or respiratory rate; see Table 1) during the
1 min prior to the onset of hypoxia and the first 1 min of
stable hypoxia (i.e. excluding the first 30 s of hypoxia).
Chronic hypoxic exposure of mice and
bromodeoxyuridine labelling
Mice were housed in a normobaric chamber containing
10% oxygen for 7 days with controlled temperature,
humidity and carbon dioxide levels, and free access to
foodandwater, as describedpreviously (Bishop et al.2013)
and removed from this chamber only for plethysmography
testing at 48 h. All mice were 20–35 g body weight at the
start of the procedure.Micewere given 50mgkg−1 bromo-
deoxyuridine (BrdU, Sigma) by intraperitoneal injection
immediately prior to the start of hypoxia exposure (day
0) followed by supplementation of drinking water with
1 mg ml−1 BrdU until termination of the experiment,
C© 2015 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 1. Acute hypoxic ventilatory responses after conditional Phd2 inactivation in adult mice
Hypoxic ventilatory response
Acute hypoxic stimulus Phd2f/f Phd2f/f;CreER P value
Minute ventilation (ml min−1 g−1) 10% O2/3% CO2 4.44 ± 0.44 7.19 ± 0.60 0.003
10% O2 1.52 ± 0.40 2.18 ± 0.46 0.286
Tidal volume (ml g−1) 10% O2/3% CO2 9.11 ± 0.53 15.14 ± 1.10 <0.001
10% O2 2.83 ± 0.40 4.84 ± 0.51 0.009
Respiratory rate (breaths min−1) 10% O2/3% CO2 98.9 ± 42.8 97.53 ± 18.6 0.975
10% O2 47.0 ± 34.7 49.1 ± 27.3 0.961
Minute ventilation, tidal volume and respiratory rate in response to the indicated acute hypoxic stimulus, following tamoxifen-induced
recombination. Mean ± SEM; n = 6 littermate pairs; P < 0.05 highlighted in bold type.
as described previously (Pardal et al. 2007; Bishop et al.
2013).
Blood measurements
Blood was taken from the tail vein of mice using hepa-
rinised capillary tubes, and haematocrits were measured
using a haematocrit centrifuge (model C-MH30, Unico,
Dayton, NJ, USA).
Immunohistochemistry
Mice were killed by overdose of isoflurane and
exsanguination followed by immediate dissection of
CBs and fixation in 4% paraformaldehyde/PBS over-
night prior to transfer into 70% ethanol and processing.
Paraffin-embedded tissue samples were sectioned to
4 μm thickness and immunostained with a poly-
clonal anti-tyrosine hydroxylase (TH) antibody (Novus
Biologicals, Abingdon, UK) as previously described
(Bishop et al. 2013), or with an anti-BrdU antibody
according to the manufacturer’s instructions (Becton
Dickinson, Oxford, UK). To quantify BrdU-positive cells,
the density of positively stained cells was estimated using
Image J software; adjacent sections were immunostained
for TH to delineate the CB. Stereological analyses of
TH-positive cell density, TH-positive cell number and
CB volume were performed using Image J software on
every fourth section throughout CBs harvested frommice
8–9 weeks after tamoxifen treatment.
Statistical analysis
Data are shown as mean ± SEM. Statistical analyses were
performed using unpaired Student’s t tests. For repeated
measures, data were analysed by ANOVA, followed by
Tukey’s test or t tests with Holm–Sidak correction for
multiple comparisons, as appropriate. P values < 0.05
were considered significant.
Results
Enhanced ventilatory responses after conditional
PHD2 inactivation in adult mice
To better define the role of PHD2 in regulating venti-
latory acclimatisation we first examined the effect of
inducible inactivation of PHD2 on the HVR using Phd2f/f;
Rosa26+/CreERT2 (here after referred to as Phd2f/f;CreER)
mice. Administration of tamoxifen at 6 weeks of age
causes general inactivation of PHD2 by Cre recombinase-
mediated excision of sequences encoding the PHD2
catalytic domain. Ventilation was analysed in conscious,
unrestrained Phd2f/f;CreER mice by whole animal
plethysmography before, during and after a 5 min acute
hypoxic stimulus both before and after (measured 10 days
after the first dose) tamoxifen treatment. Responses were
compared with those of littermate control Phd2f/f mice
lacking the Rosa26CreERT2 allele (Fig. 1; Table 1).
In control Phd2f/f animals prior to tamoxifen treatment,
acute exposure to hypoxia (10% oxygen) elicited
an immediate but poorly sustained HVR (Fig. 1A).
The response to unregulated breathing of a hypo-
xic atmosphere decreases as hyperventilation induces
respiratory alkalosis, which in turn depresses ventilation.
This can be offset by adding a small concentration of
carbon dioxide to the hypoxic atmosphere used for acute
stimulation. Thus, control mice exposed to 10% oxygen
with 3% carbon dioxide (as described by Bishop et al.
2013; Slingo et al. 2014), and based on published data
which show that adding 3% carbon dioxide prevents a
major rise in arterial pH or fall in PaCO2 when mice are
exposed to 7% oxygen (Ishiguro et al. 2006), exhibited a
more sustainedHVR (Fig. 1D) than when exposed to 10%
oxygen alone (Fig. 1A). Treatment of the control Phd2f/f
mice with tamoxifen did not alter HVR with either 10%
oxygen or 10% oxygen with 3% carbon dioxide (Fig. 1B
vs. A, E vs. D).
In Phd2f/f;CreER mice, acute exposure to hypoxia
(either 10% oxygen or 10% oxygen with 3% carbon
dioxide) elicited HVRs of similar magnitude to those
C© 2015 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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of littermate control Phd2f/f mice when tested prior
to tamoxifen treatment (Fig. 1A, D). Ten days after
the first dose of tamoxifen genomic recombination was
efficient (data not shown) and mice appeared healthy,
without visible abnormalities. Ventilatory responses to
10% oxygen and 10% oxygen with 3% carbon dioxide
were again tested. Large increases in HVR were observed
in Phd2f/f;CreERmice compared to their Phd2f/f littermate
controls. Responses were particularly clearly observed in
the sustainedHVR observed in response to breathing 10%
oxygen with 3% carbon dioxide (Fig. 1E; Table 1). These
were similar inmagnitude and character to those observed
after 7 days of pre-exposure to hypoxia (Bishop et al. 2013,
and see below) and primarily involved an increase in tidal
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Figure 1. Acute hypoxic ventilatory responses before and after conditional Phd2 inactivation in adult
mice
Minute ventilation before, during and after an acute hypoxic exposure to 10% oxygen (A–C, closed bars), or 10%
oxygen with added 3% carbon dioxide (D–F, open bars) in littermate controlled Phd2f/f versus Phd2f/f;CreER mice.
Animals studied before (A and D) and 10 days after (B and E) starting tamoxifen treatment. Hypoxic ventilatory
responses (HVRs) calculated from B and E are shown in C and F, respectively. Mean ± SEM, n = 6 littermate pairs;
∗∗P < 0.01.
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volume (Table 1). Furthermore, this was accompanied by
a small but significant increase in basal minute ventilation
(in 21% oxygen) in Phd2f/f;CreER mice compared to
Phd2f/f controls (4.09 ± 0.3 vs. 3.10 ± 0.3 ml min−1 g−1,
P= 0.03). These findings reveal that induced, general loss
of PHD2 enhances the acute ventilatory response to hypo-
xia, and over a comparable period of time to ventilatory
acclimatisation to hypoxia, consistent with the hypothesis
that hypoxic inhibition of PHD2 plays a key mechanistic
role in this process.
Combined inactivation of PHD2 and HIF-α isoforms
As PHD2 regulates bothHIF-1α andHIF-2α and has been
reported to hydroxylate many non-HIF substrates, we
next analysed whether the PHD2-dependent ventilatory
phenotypes are mediated through HIF regulation and
whether they are specifically dependent on a particular
HIF-α isoform.
In the first instance, we tested this by combining
acute general inactivation of PHD2 with that of either
HIF-1α or HIF-2α by breeding Phd2f/f;Hif-1αf/f;CreER or
Phd2f/f;Hif-2αf/f;CreER mice and comparing ventilatory
responses to those of Phd2f/f;CreER control mice, after
treatment with tamoxifen. HVR was measured in
response to both 10% oxygen and 10% oxygen with 3%
carbon dioxide. Prior to tamoxifen treatment, similar
HVR values were obtained in all mice, regardless of
genotype (data not shown). As previously, ventilatory
responses were re-measured 10 days after the first
dose of tamoxifen, at which point efficient genomic
recombination had taken place (data not shown), but
other systemic responses such as changes in haematocrit
had not developed. Effects were again more clearly
observed on the sustained HVR observed with 10%
oxygen and 3% carbon dioxide. HVRs to this stimulus
were significantly reduced in Phd2f/f;Hif-2αf/f;CreERmice
but not Phd2f/f;Hif-1αf/f;CreER mice when compared to
Phd2f/f;CreER control mice (Fig. 2A–C; Table 2). There
were no significant effects on basal ventilation in either
case, despite a trend towards reduced ventilation in
Phd2f/f;Hif-2αf/f;CreER mice. The results indicate that the
acute ventilatory effects of PHD2 inactivation can be
largely reversed through concomitant acute inactivation
of HIF-2α but not HIF-1α.
After longer periods of PHD2 inactivation these
interventions have been reported to result in major
changes in haematopoiesis. To enable comparison of
our work with those reports, we measured haematocrits
6 weeks following tamoxifen treatment. In line with pre-
vious reports (Takeda et al. 2007, 2008; Minamishima
et al. 2008), Phd2f/f;CreER mice developed severe poly-
cythaemia (Table 6A) and hepatosplenomegaly (data
not shown). Concomitant inactivation of HIF-2α
(tamoxifen-treated Phd2f/f;Hif-2αf/f;CreER mice), but not
HIF-1α (tamoxifen-treated Phd2f/f;Hif-1αf/f;CreER mice),
ablated the development of polycythaemia (Table 6A).
These findings are thus in line with previous findings
using similar but not identicalmouse lines (Arsenault et al.
2013; Franke et al. 2013), and confirm the dominant role
of HIF-2α in regulating erythropoiesis.
Ventilation measurements in these mice were made
prior to the onset of the polycythaemia when mice
appeared healthy, at the earliest time point following
tamoxifen treatment when recombination could be con-
firmed. Nevertheless, these models may be confounded
by, for example, changes in iron status that precede
the onset of polycythaemia. To confirm the findings
on the HIF-α isoform dependence of PHD2-dependent
increases in HVR in an independent genetic model,
we analysed the HIF-α dependence of the ventilatory
effects observed in Phd2+/− mice (Bishop et al.
2013) using double heterozygotes (Phd2+/−;Hif-1α+/− or
Phd2+/−;Hif-2α+/– animals). These mice developed
normally andwere essentially indistinguishable fromwild-
type mice under normoxic conditions; haematocrits
were normal in Phd2+/− mice, with Phd2+/−;Hif-1α+/−
and Phd2+/−;Hif-2α+/− mice being only very mildly
polycythaemic/anaemic, respectively, when compared to
Phd2+/− mice (Table 6A).
The required intercrosses generated mice on a mixed
genetic background rather than the C57BL/6 back-
ground on which we had previously observed enhanced
HVR in Phd2+/− animals (Bishop et al. 2013), and
HVR has been reported to vary with genetic back-
ground (Han et al. 2002; Balbir et al. 2007). For those
reasons, we first confirmed enhanced HVRs in Phd2+/−
versus wild-type littermate mice (data not shown).
The effect of heterozygous inactivation of HIF-1α or
HIF-2α on the Phd2+/− ventilatory responses was tested
by directly comparing HVRs in Phd2+/– mice with
littermates that were also heterozygous for the different
HIF-α isoforms. HVRs were significantly reduced in
Phd2+/−;Hif-2α+/− versus Phd2+/− mice, but not in the
equivalent HIF-1α comparison (Fig. 2D–F; Table 3).
The findings are therefore consistent with those follo-
wing tamoxifen-inducible general inactivation. Further-
more, the results demonstrate that although ventilatory
control and erythropoiesis are both strongly regulated
by PHD2 and HIF-2α, the two processes can be
uncoupled from each other, with changes in HVR
occurring independently of erythropoietic stimulation, in
the different settings.
A major role for HIF-2α in ventilatory acclimatisation
to hypoxia
Given that our findings implicate HIF-2α in mediating
increased HVR in the different models of PHD2
inactivation, we proceeded to test the role of the different
C© 2015 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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HIF-α isoforms in enhancedHVR following pre-exposure
to hypoxia. This was done by measuring HVR in mice
after inactivation of HIF-1α or HIF-2α using both the
inducible and the constitutive systems, i.e. comparison of
tamoxifen-treatedHif-1α orHif-2αf/f;CreER versus Hif-1α
orHif-2αf/f control mice and comparison of heterozygous
Hif-1α or Hif-2α versus wild-type mice (Figs 3 and
4). Animals were pre-exposed to chronic hypoxia (10%
oxygen in a normobaric chamber for 7 days), starting
10 days after the first tamoxifen dose in the case of the
conditional system. HVR was measured before and after
48 h and 7 days at 10% oxygen.
Progressive respiratory acclimatisation was observed
in control (i.e. wild-type or tamoxifen-treated Hif-1αf/f
and Hif-2αf/f) mice, with a significant increase in HVR
after 48 h at 10% oxygen, which was further enhanced
after 7 days at 10% oxygen (Figs 3 and 4; Tables 4
and 5).
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Figure 2. Effect of conditional or constitutive inactivation of Hif-1α or Hif-2α on hypoxic ventilatory
responses of mice with associated inactivation of Phd2
Minute ventilation before, during and after an acute hypoxic exposure to 10% oxygen with 3% carbon dioxide
(open bars) in: A, tamoxifen-treated Phd2f/f;CreER versus Phd2f/f;Hif-1αf/f;CreER (n = 6 pairs); B, tamoxifen-treated
Phd2f/f;CreER versus Phd2f/f;Hif-2αf/f;CreER (n = 5 pairs); D, Phd2+/− versus Phd2+/−;Hif-1α+/− mice (n = 7 pairs);
and E, Phd2+/− versus Phd2+/−;Hif-2α+/− mice (n = 7 pairs). Calculated HVRs for data shown in A–B and D–E are
shown in C and F, respectively. Mean ± SEM; ∗P < 0.05.
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Table 2. Ventilatory responses after conditional inactivation of Phd2 and concomitant inactivation of Hif-1α or Hif-2α
Hypoxic ventilatory response (ml min−1 g−1)
Acute hypoxic stimulus Phd2f/f;CreER Phd2f/f;Hif-1αf/f;CreER P value
10% O2/3% CO2 4.42 ± 0.69 4.49 ± 1.01 0.95
10% O2 0.59 ± 0.77 0.45 ± 0.27 0.86
Phd2f/f;CreER Phd2f/f;Hif-2αf/f;CreER
10% O2/3% CO2 4.29 ± 0.44 2.78 ± 0.28 0.02
10% O2 1.58 ± 0.86 –0.98 ± 0.57 0.15
Acute hypoxic ventilatory responses of tamoxifen-treated Phd2f/f;CreER versus Phd2f/f;Hif-1αf/f;CreER mice (n = 6 pairs) or
tamoxifen-treated Phd2f/f;CreER versus Phd2f/f;Hif-2αf/f;CreERmice (n= 5 pairs). Values shown aremean changes in minute ventilation
(± SEM) in response to the indicated acute hypoxic stimulus. P < 0.05 highlighted in bold type.
Table 3. Acute hypoxic ventilatory responses of Phd2+/− versus Phd2+/−;Hif-1α+/− mice or Phd2+/− versus Phd2+/−;Hif-2α+/− mice
Hypoxic ventilatory response (ml min−1 g−1)
Acute hypoxic stimulus Phd2+/− Phd2+/−;Hif-1α+/− P value
10% O2/3% CO2 6.21 ± 0.81 5.61 ± 0.49 0.54
10% O2 2.04 ± 0.64 1.29 ± 0.38 0.33
Phd2+/− Phd2+/−;Hif-2α+/−
10% O2/3% CO2 5.58 ± 0.83 3.17 ± 0.46 0.03
10% O2 2.97 ± 0.73 1.26 ± 0.45 0.07
Values shown are mean changes in minute ventilation (± SEM) in response to the indicated acute hypoxic stimulus; n = 7 littermate
pairs for each genotype; P < 0.05 highlighted in bold type.
Neither acute inactivation of HIF-1α in
tamoxifen-treated Hif-1αf/f;CreER mice (compared
to control, tamoxifen-treated Hif-1αf/f) nor constitutive
loss of HIF-1α inHif-1α+/− mice (compared to wild-type
littermates) significantly altered HVR measured over
48 h to 7 days at 10% oxygen (Fig. 3; Tables 4A and
5A), although there was a trend towards decreased
HVRs in Hif-1αf/f;CreER and Hif-1α+/− mice after
48 h of hypoxia (Tables 4A and 5A). In contrast,
acute inactivation of HIF-2α (tamoxifen-treated
Hif-2αf/f;CreER mice) and constitutive inactivation of
HIF-2α in Hif-2α+/− mice significantly reduced the
increases in HVR after 48 h or 7 days of hypoxia (Fig. 4;
Tables 4B and 5B). Interestingly, effects on HVR at
baseline (i.e. prior to chronic hypoxia pretreatment)
were also observed in Hif-2αf/f;CreER mice (Fig. 4A;
Table 4B) without any significant effect on basal venti-
lation in normoxia; a similar trend towards a reduction
in HVRs was noted in normoxic Hif-2α+/− mice but this
did not reach statistical significance (Fig. 4E; Table 5B).
Together these results demonstrate that, regardless of
the genetic model, HIF-2α plays a major role in
ventilatory acclimatisation to hypoxia (and contributes to
maintenance of basal HVR), consistent with dependence
of the enhanced HVR on HIF-2α in PHD2 deficient
animals.
Although both Hif-2α+/− and tamoxifen-treated
Hif-2αf/f;CreER mice had reduced ventilatory
acclimatisation to hypoxia, they differed in their
erythropoietic status. Erythropoiesis was unaffected
by loss of HIF-2α or HIF-1α in Hif-2α+/− or
Hif-1α+/− mice (Table 6B); likewise, it was unaffected
in tamoxifen-treated Hif-1αf/f;CreER mice (Table 6B). In
contrast, hypoxia-induced erythropoiesis was abrogated
in tamoxifen-treated Hif-2αf/f;CreER mice (Table 6B).
This is consistent with the reported importance of
PHD2/HIF-2α in erythropoietic control (Arsenault et al.
2013; Franke et al. 2013), but confirms that erythropoietic
stimulation and changes in ventilatory control occur
independently.
Essential role of HIF-2α in hypoxia-induced cell
proliferation within the CB
Increasedventilatory sensitivity after hypoxic exposurehas
been associatedwith growth of the CB in a range of species
(Kay & Laidler, 1977; McGregor et al. 1984). CBs from
Phd2+/− mice show hyperplasia in the absence of hypoxic
C© 2015 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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exposure, which may contribute to the exaggerated HVR
(Bishop et al. 2013). We therefore analysed the role of
HIF-α isoforms in the cellular proliferative response to
hypoxia in CBs by measuring BrdU incorporation during
hypoxic exposure (10% oxygen for 7 days) (as described
by Pardal et al. 2007; Bishop et al. 2013). Responses were
compared in mice with either constitutive or conditional
loss of HIF-1α or 2α.
In control mice (wild-type, or tamoxifen-treated
Hif-1αf/f or 2αf/f mice without the Cre allele), striking
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Figure 3. Effect of conditional or constitutive inactivation of Hif-1α on the hypoxic ventilatory response
in mice before and after ventilatory acclimatisation to chronic hypoxia
Minute ventilation before, during and after an acute hypoxic exposure to 10% oxygen with 3% carbon dioxide
(open bars). Comparisons were tamoxifen-treated Hif-1αf/f;CreER versus Hif-1αf/f littermates (n = 7 pairs)(A–D);
Hif-1α+/− versus wild-type littermates (n = 6 pairs) (E–H). Animals were studied immediately before (0 h, A, E) or
after (48 h, B, F; 7 days, C, G) exposure to chronic hypoxia (CH). D and H, hypoxic ventilatory responses (HVR)
calculated from changes in minute ventilation before and after exposure to CH for the indicated times. For mice
bearing the conditionally inactivated allele, HVR values are shown before and after tamoxifen (TMX). Values shown
are mean ± SEM.
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incorporation of BrdU was observed after 7 days at 10%
oxygen, consistentwith previous descriptions (Pardal et al.
2007; Bishop et al. 2013). Acute conditional inactivation
of HIF-2α resulted in near total loss of BrdU staining,
which was reduced to the low background levels observed
in normoxic animals (Fig. 5B). In contrast, conditional
inactivation of HIF-1α had no discernible effect (Fig. 5B).
Effects of heterozygous loss of HIF-α were less striking:
with HIF-1α no discernible effect was apparent, whereas
with HIF-2α, reduced BrdU staining was observed that
Figure 4. Effect of conditional or constitutive inactivation of Hif-2α on the hypoxic ventilatory response
in mice before and after ventilatory acclimatisation to chronic hypoxia
Minute ventilation before, during and after an acute hypoxic exposure to 10% oxygen with 3% carbon dioxide
(open bars). Comparisons were tamoxifen-treated Hif-2αf/f;CreER versus Hif-2αf/f littermates (n = 7 pairs) (A–D);
Hif-2α+/− versus wild-type littermates (n = 6 pairs) (E–H). Animals were studied immediately before (0 h, A, E) or
after (48 h, B, F; 7 days, C, G) exposure to chronic hypoxia (CH). D and H, hypoxic ventilatory responses (HVR)
calculated from changes in minute ventilation before and after exposure to CH for the indicated times. For mice
bearing the conditionally inactivated allele, HVR values are shown before and after tamoxifen (TMX). Mean ± SEM;
∗∗P < 0.01, ∗∗∗P < 0.001.
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Table 4. Acute hypoxic ventilatory responses of mice after conditional inactivation of Hif-1α or Hif-2α followed by chronic hypoxia
exposure
(A)
Hypoxic ventilatory response (ml min−1 g−1)
Acute hypoxic stimulus Chronic hypoxia duration Hif-1αf/f Hif-1αf/f;CreER t test P value ANOVA P value
10% O2/ 3% CO2 0 h 2.82 ± 1.05 3.38 ± 0.26 0.500 <0.0001
48 h 6.13 ± 0.39 6.03 ± 0.48 0.901
7 days 6.59 ± 0.64 6.93 ± 0.47 0.682
ANOVA P value 0.6305 0.8227
10% O2 0 h 0.99 ± 0.51 0.39 ± 0.22 0.358 0.0015
48 h 2.58 ± 0.72 1.31 ± 0.38 0.053
7 days 2.27 ± 0.62 2.51 ± 0.36 0.290
ANOVA P value 0.0699 0.6683
(B)
Hypoxic ventilatory response (ml min−1 g−1)
Acute hypoxic stimulus Chronic hypoxia duration Hif-2αf/f Hif-2αf/f;CreER t test P value ANOVA P value
10% O2/ 3% CO2 0 h 4.68 ± 0.37 2.83 ± 0.36 0.0060 <0.0001
48 h 7.41 ± 0.66 3.89 ± 0.55 0.0022
7 days 8.55 ± 0.48 4.14 ± 0.45 0.0004
ANOVA P value 0.0002 0.0212
10% O2 0 h 0.73 ± 0.64 –0.13 ± 0.51 0.24479 0.0013
48 h 2.10 ± 0.39 0.78 ± 0.76 0.08107
7 days 3.72 ± 0.27 1.16 ± 0.43 0.00144
ANOVA P value 0.0061 0.2287
Hypoxic ventilatory responses of: A, Hif-1αf/f;CreER versus Hif-1αf/f; and B, Hif-2αf/f;CreER versus Hif-2αf/f mice after tamoxifen-induced
recombination (0 h), followed by 48 h and 7 days of exposure to 10% oxygen. Values shown are mean changes in minute ventilation
(± SEM) in response to the indicated acute hypoxic stimulus; n = 7 littermate pairs for each genotype. Comparisons were made using
two-way ANOVAs (right-hand column P value = chronic hypoxia factor; bottom row P value = genotype factor; right column, bottom
row P value = chronic hypoxia/genotype interaction factor), followed by t tests (with Holm–Sidak correction) for analysis of individual
time points; P < 0.05 highlighted in bold type.
did not reach statistical significance (Fig. 5A). The
effect of conditional HIF-1α and HIF-2α inactivation
on CB morphology was further tested in animals that
were maintained under normoxia. HIF-1α or HIF-2α
inactivation did not significantly alter CB volume, Type
I cell number or Type I cell density, and tissues from
all genotypes appeared to have qualitatively normal
histological structure (Fig. 5C).
Discussion
Our findings indicate that, despite the long-term changes
in CB morphology that are associated with constitutive
heterozygous inactivation of PHD2, acute conditional
inactivation of components of the PHD–HIF system in
the adult have very major effects on ventilatory responses
to hypoxia.
Specifically, inducible inactivation of PHD2 increased
ventilatory sensitivity to hypoxia, whereas combined
inducible inactivation of PHD2 and HIF-2α compensated
for this effect, and inducible inactivation ofHIF-2α largely
ablated enhanced ventilatory sensitivity after chronic
hypoxic exposure. These effects on ventilatory sensitivity
were large and extended, in the case of inducible HIF-2α
inactivation, to a significant reduction in basal HVR. By
contrast, the effects of inducible inactivation of HIF-1α
were modest.
Our work does not exclude developmental or longer
term effects of the PHD–HIF system on ventilatory
sensitivity to hypoxia, but the effects of acute conditional
inactivation were as large as, or larger than, those
of constitutive heterozygous inactivation of different
components, possibly reflecting the potential for biallelic
inactivation in the inducible models. As with the studies
of combined inactivation of Phd2 and Hif-α genes in
the acute model, heterozygous inactivation of HIF-2α
had substantially greater effects on the enhanced HVR
in Phd2+/− animals than heterozygous inactivation of
HIF-1α. In each model effects of HIF-2α inactivation on
the enhanced HVR observed after chronic hypoxia, and
C© 2015 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 5. Acute hypoxic ventilatory responses of Hif-1α+/− or Hif-2α+/− mice before and after chronic hypoxia exposure
(A)
Hypoxic ventilatory response (ml min−1 g−1)
Acute hypoxic stimulus Chronic hypoxia duration WT Hif-1α+/− t test P value ANOVA P value
10% O2/ 3% CO2 0 h 3.89 ± 0.79 3.24 ± 0.53 0.562 0.0001
48 h 7.13 ± 0.62 5.74 ± 0.87 0.220
7 days 7.66 ± 1.02 8.46 ± 0.80 0.475
ANOVA P value 0.4470 0.4363
10% O2 0 h 1.50 ± 0.31 1.20 ± 0.80 0.771 0.0021
48 h 3.88 ± 0.75 2.63 ± 0.76 0.250
7 days 4.24 ± 0.98 4.86 ± 0.75 0.563
ANOVA P value 0.5947 0.4986
(B)
Hypoxic ventilatory response (ml min−1 g−1)
Acute hypoxic stimulus Chronic hypoxia duration WT Hif-2α+/− t test P value ANOVA P value
10% O2/3% CO2 0 h 3.32 ± 0.70 2.41 ± 0.65 0.378 <0.0001
48 h 5.99 ± 0.65 3.56 ± 0.40 0.020
7 days 6.85 ± 0.90 4.96 ± 0.82 0.067
ANOVA P value 0.0527 0.3433
10% O2 0 h 2.18 ± 0.55 0.59 ± 0.88 0.129 0.0009
48 h 3.61 ± 0.50 1.51 ± 0.63 0.048
7 days 5.43 ± 1.09 4.19 ± 0.45 0.233
ANOVA P value 0.0068 0.8566
Hypoxic ventilatory responses of: A, Hif-1α+/− versus WT; and B, Hif-2α+/− versus WT mice after 0 h, 48 h and 7 days of exposure to
10% oxygen. Values shown are mean changes in minute ventilation (±SEM); n = 6 littermate pairs for each genotype. Comparisons
were made using two-way ANOVAs (right-hand column P value = chronic hypoxia factor; bottom row P value = genotype factor;
right column, bottom row P value = chronic hypoxia/genotype interaction factor), followed by t tests (with Holm–Sidak correction)
for analysis of individual time points; P < 0.05 highlighted in bold type.
after PHD2 inactivation, were similar, strongly supporting
the hypothesis that effects of hypoxia are mediated by
PHD2 activity on HIF-2α.
The importance of HIF-2α in these responses is
consistent with high expression of this isoform in
sympatho-adrenal tissues (Tian et al. 1998). It is also
consistent with findings in human monogenic diseases
and analyses of associated phenotypes in mouse models
of the relevant humanmutations. Thus, the hypomorphic
Vhl allele associated with Chuvash polycythaemia, and
with increased ventilatory sensitivity to hypoxia,manifests
somewhat greater dysregulation of HIF-2α than HIF-1α
(Ang et al. 2002; Smith et al. 2006; Hickey et al. 2010).
Similarly, ‘knock-in’ mouse models of inherited human
polycythaemia [‘loss of function’ Phd2P249R/+ (Arsenault
et al. 2013) and ‘gain of function’ Hif-2αG536W/G536W
(Tan et al. 2013) mice] manifest altered (albeit more
minor) effects on ventilatory sensitivity consistent with
our findings.
Other work has emphasised the importance of HIF-1α,
at least in the setting of constitutive heterozygous
inactivation of Hif-α alleles. This work described reduced
VAH in Hif-1α+/− animals following 72 h under hypo-
baric hypoxia (0.4 atmospheres) (Kline et al. 2002;
Yuan et al. 2013). Although trends towards reduced
VAH following inactivation of HIF-1α were observed in
several of our datasets, these did not reach significance
in any one comparison, and were generally much less
than those following inactivation of HIF-2α. In contrast
with our findings, Peng et al. (2011) describe increased
sensory discharges in hypoxia from CBs isolated from
Hif-2α+/– mice and ventilatory instability with sighing
and apnoea in the intact animals. They also describe
an interplay between HIF-1α heterozygosity and HIF-2α
heterozygosity, such thatdoubleheterozygosity forHIF-1α
and HIF-2α compensated for the effects of HIF-1α
heterozygosity on ventilatory sensitivity (Yuan et al. 2013).
We are not clear as to the reasons for these differences from
our findings. Although we did not observe ventilatory
instability in ourHif-2α+/− animals, it is possible that such
aphenotypemight be related todifferences inbackground,
and might obscure, or even reflect, the abnormalities
of ventilatory control in response to hypoxia that we
observed.
C© 2015 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 6. Haematocrit values
(A)
Haematocrit (%)
Phd2f/f 44 ± 4
Phd2f/f;CreER 79 ± 2∗∗∗∗
Phd2f/f;Hif-1αf/f;CreER 78 ± 4∗∗∗∗
Phd2f/f;Hif-2αf/f;CreER 53 ± 9§§§
Wild-type 51 ± 1
Phd2+/− 53 ± 1
Phd2+/−;Hif-1α+/− 56 ± 1∗∗§
Phd2+/−;Hif-2α+/− 49 ± 1§
(B)
Post-CH haematocrit (%)
Hif-1αf/f 62 ± 2
Hif-1αf/f;CreER 61 ± 1
Hif-2αf/f 62 ± 0.5
Hif-2αf/f;CreER 49 ± 0.5∗∗
Wild-type 63 ± 4
Hif-1α+/− 61 ± 4
Wild-type 60 ± 1
Hif-2α+/− 59 ± 3
A, mean haematocrit values (± SEM) in age-matched male
mice; values were measured 6 weeks after starting tamoxifen
treatment for conditional mice. B, mean haematocrit values (±
SEM) after 7 days at 10% oxygen (after chronic hypoxia, CH)
(starting 10 days after tamoxifen treatment for the conditional
mice). Data were analysed by Tukey’s multiple comparison
test; significantly different from wild-type or tamoxifen-treated
Phd2f/f or Hif-2αf/f control mice: ∗∗P < 0.01, ∗∗∗∗P < 0.0001;
significantly different from tamoxifen-treated Phd2f/f;CreER or
Phd2+/− mice: §P < 0.05; §§§P < 0.001; n = 6–13 mice per
genotype.
One difference in our studies was the use of
10% oxygen with 3% carbon dioxide to compensate
for hyperventilation-induced hypocapnia. This stimulus
was used instead of the computer-regulated end-tidal
clamping of carbon dioxide that has been used to clarify
the measurement of ventilatory sensitivity to hypoxia in
humans (Howard & Robbins, 1995), but is not feasible
in mice. Our calculations indicated that, at the levels
of hyperventilation that were induced, this manoeuvre
provides approximate compensation for hypocapnia, and
thus much more closely induces pure hypoxaemia than
simple inhalation of 10% oxygen. Consistent with results
in humans, HVRs were much better sustained when these
attempts to compensate for hypocapnia were made than
when they were not, and the effects of interventions on
the size of the HVR were more clearly seen. Nevertheless,
we cannot exclude that some animals have been sub-
jected to an additional hypercapnic stimulus under these
conditions, potentially acting outside theCB.We therefore
analysed HVRs both in response to 10% oxygen with 3%
carbon dioxide and in response to 10% oxygen alone,
and have provided all datasets. In general, responses to
both stimuli showed similar trends from interventions,
although responses to 10% oxygen were smaller andmore
variable and the effects of interventions less frequently
reached statistical significance.
Importantly, however, because ventilatory sensitivity
in mice is reported to vary with genetic background
(Han et al. 2002; Balbir et al. 2007), our observations
on the dominant importance of PHD2 and HIF-2α were
observed clearly using differently derived inactivating
HIF-α isoforms and on the cellular proliferation that
is observed in the CB in response to sustained hypo-
xia. Hypoxia-induced cellular proliferation as assessed by
BrdU staining was specifically, and almost totally, ablated
by acute inactivation of Hif-2α. In contrast, CBs from
animals with either acute or constitutive heterozygous
inactivation of Hif-1α were indistinguishable from
controls.
Although changes in HVR and in these proliferative
responses were altered in parallel, it is not yet precisely
clear how they are connected. Nevertheless, quantitative
differences in the effects of HIF-2α heterozygosity on
HVR and on cellular proliferation, taken together with
the rapid (within hours) effects of sustained hypoxia on
HVR (reviewed by Robbins, 2007), suggest that enhanced
HVR is not simply a reflection of increased CB mass.
Further work will be required to understand how the
role(s) of HIF-2α in each process are interlinked. Inter-
estingly, cellular proliferation within the CB has been
demonstrated to depend on an interplay between the Type
I neurosecretory ‘glomus’ cells and Type II ‘supporting’
cells (Pardal et al. 2007; Platero-Luengo et al. 2014).
Proliferation originates in stem-like Type II cells that
then develop into Type I cells (Pardal et al. 2007), but is
dependent on paracrine responses fromhypoxia-activated
Type I cells (Platero-Luengo et al. 2014). Although the
rapid electrophysiological events that activate Type I cells
in response to hypoxia are believed to be independent of
HIF andHIF hydroxylase activity, our data clearly indicate
that the integrity of HIF-2α is required at some stage in
the events linking hypoxic exposure to proliferation and
differentiation of cells within the CB.
It is also likely that other components of the HIF hydro-
xylase system are important in defining CB morphology
through developmental or adaptive processes. For
instance, inactivation of PHD3 leads to altered CB cell
morphology, probably through defective developmental
culling of sympathoadrenal neurones (Bishop et al. 2008),
but Phd3−/− mice show normal HVR (Bishop et al.
2013). Furthermore, inactivation of VHL in Type I cells
by TH-driven Cre recombinase results in atrophy of the
CB (Macias et al. 2014), suggesting either that the very
high levels of HIF-α associated with complete inactivation
of VHL impair CB cell viability or that some other
C© 2015 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Figure 5. Hypoxia-induced cellular proliferation and CB morphology in mice with conditional or
constitutive inactivation of Hif-1α or Hif-2α
Immunostaining for BrdU performed on CB sections from: A, Hif-1α+/− or Hif-2α+/− compared to wild-type
(WT) littermates; and B, tamoxifen-treated Hif-1αf/f;CreER or Hif-2αf/f;CreER compared to Hif-1αf/f or Hif-2αf/f
littermate controls. All mice were treated with BrdU and exposed to 10% oxygen for 7 days prior to being
killed and preparation of tissues. Representative images from each genotype are shown in Aa and Ba where
BrdU-positive cells are stained brown (scale bar = 0.04 mm). Ab–c and Bb–c, Quantification of BrdU-positive cells
in CBs ofHif-1α+/− (Ab) orHif-2α+/− (Ac) compared toWT littermates and tamoxifen-treatedHif-1αf/f;CreER (Bb) or
Hif-2αf/f;CreER (Bc) compared to controls of similar genotype but lacking the CreER allele (n= 6 pairs per genotype).
C, immunostaining for tyrosine hydroxylase (TH) performed on CB sections from Hif-1αf/f;CreER or Hif-2αf/f;CreER
compared to Hif-1αf/f or Hif-2αf/f littermate mice, 8–9 weeks after tamoxifen treatment. Morphometric analysis
of CB volume, TH-positive cell number and TH-positive cell density in CBs of Hif-1αf/f;CreER (Ca) or Hif-2αf/f;CreER
(Cb) compared to controls lacking the CreER allele (n = 3 pairs per genotype). Cc, representative images from
each genotype with TH-positive cells stained brown (scale bar = 0.04 mm). Values shown are mean ± SEM;
∗∗∗∗P < 0.0001.
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consequence of defective VHL function has the same
effect.
Nevertheless, despite these complexities, the current
work reveals the importance of specific components
of the HIF hydroxylase system (the PHD2 – HIF-2α
enzyme–substrate couple) in mediating both anatomical
and physiological responses that underlie ventilatory
acclimatisation to hypoxia.
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